PACB

Pacific Biosciences of California, Inc. NASDAQ

Healthcare ·Medical - Devices ·US · pacb.com

$1.55

Mkt Cap $468.1M

52w Low $0.85 37.2% of range 52w High $2.73

50d MA $1.48 200d MA $1.68

P/E (TTM) -0.9x

EV/EBITDA -36.7x

P/B 89.9x

Debt/Equity 142.0x

ROE -10214.5%

P/FCF -4.9x

RSI (14) —

ATR (14) —

Beta 2.33

50d MA $1.48

200d MA $1.68

Avg Volume 6.4M

About

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparatio…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 12, 2026	AMC	-0.19	-0.12	+36.8%	1.84	+2.7%	-7.1%	-14.1%	-11.4%	-8.7%	-12.5%	-26.1%	—
Nov 5, 2025	AMC	-0.16	-0.12	+25.0%	1.92	-5.7%	-7.3%	-8.3%	-8.3%	-3.1%	-9.4%	+24.5%	—
Aug 7, 2025	AMC	-0.18	-0.13	+27.8%	1.26	+15.1%	+7.1%	+0.0%	-4.0%	+1.6%	-2.4%	-0.8%	—
May 8, 2025	AMC	-0.19	-0.15	+21.1%	1.20	-0.8%	-6.7%	-8.3%	-4.2%	-8.3%	-11.7%	+0.0%	—
Feb 13, 2025	AMC	-0.20	-0.20	+0.0%	1.48	-3.4%	+25.0%	+26.4%	+19.6%	+10.8%	+4.1%	-16.2%	—
Nov 7, 2024	AMC	-0.22	-0.22	+0.0%	2.45	-11.0%	-6.1%	+0.4%	-9.8%	-19.2%	-24.1%	-11.0%	—
Aug 7, 2024	AMC	-0.24	-0.20	+16.7%	1.53	-11.1%	+9.2%	+3.9%	-6.5%	-2.6%	-11.8%	+3.3%	—
May 9, 2024	AMC	-0.28	-0.29	-3.6%	1.72	+0.0%	+2.9%	+12.2%	+29.7%	+25.0%	+27.3%	+9.9%	—
Feb 15, 2024	AMC	-0.29	-0.31	-6.9%	6.67	-4.0%	-13.9%	-20.7%	-23.8%	-23.1%	-23.4%	-45.0%	—
Oct 30, 2023	AMC	-0.33	-0.26	+21.2%	7.11	-5.3%	-13.1%	-16.0%	-8.3%	+1.5%	-4.4%	+23.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 14	Barclays	Maintains	Underweight → Underweight	—	$1.45	$1.47	+1.4%	+8.3%	+10.3%	+12.4%	+16.6%	+20.0%
Mar 6	Barclays	Downgrade	Equal Weight → Underweight	—	$1.52	$1.46	-3.9%	-9.2%	-8.6%	-9.9%	-11.2%	-16.4%
Dec 15	Barclays	Maintains	Equal Weight → Equal Weight	—	$2.12	$2.15	+1.4%	+0.0%	-4.7%	-9.0%	-11.3%	-13.2%
Nov 11	Piper Sandler	Maintains	Neutral → Neutral	—	$1.76	$1.78	+1.1%	+5.7%	-1.1%	-7.4%	-8.5%	-10.8%
Nov 10	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.76	$1.83	+4.0%	+0.0%	+5.7%	-1.1%	-7.4%	-8.5%
Aug 11	Piper Sandler	Maintains	Neutral → Neutral	—	$1.35	$1.36	+0.7%	-6.7%	-10.4%	-5.2%	-8.9%	-3.0%
Jun 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$1.20	$1.18	-1.7%	+1.7%	+7.5%	+7.5%	+3.3%	+7.5%
May 15	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.10	$1.10	+0.0%	-3.6%	-6.4%	-7.3%	-7.3%	-10.8%
May 15	Piper Sandler	Maintains	Neutral → Neutral	—	$1.10	$1.10	+0.0%	-3.6%	-6.4%	-7.3%	-7.3%	-10.8%
Apr 10	Canaccord Genuity	Maintains	Buy → Buy	—	$1.45	$1.45	+0.0%	-4.8%	-6.2%	-9.0%	-12.4%	-17.2%
Mar 25	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$1.33	$1.32	-0.8%	-1.5%	-4.5%	-6.8%	-14.3%	-11.3%
Feb 20	Piper Sandler	Maintains	Neutral → Neutral	—	$1.77	$1.75	-1.1%	-7.3%	-13.0%	-7.9%	-11.9%	-7.9%
Feb 18	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.85	$1.84	-0.5%	+1.1%	-4.3%	-11.4%	-16.8%	-11.9%
Feb 18	Goldman Sachs	Maintains	Neutral → Neutral	—	$1.85	$1.84	-0.5%	+1.1%	-4.3%	-11.4%	-16.8%	-11.9%
Feb 14	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.48	$1.43	-3.4%	+25.0%	+26.4%	+19.6%	+10.8%	+4.1%
Jan 23	Goldman Sachs	Maintains	Neutral → Neutral	—	$1.81	$1.76	-2.8%	-8.8%	-6.6%	-7.7%	-11.0%	-13.8%
Nov 11	Piper Sandler	Maintains	Neutral → Neutral	—	$2.30	$2.34	+1.7%	+7.0%	-3.9%	-13.9%	-19.1%	-30.4%
Nov 11	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$2.30	$2.34	+1.7%	+7.0%	-3.9%	-13.9%	-19.1%	-30.4%
Nov 11	UBS	Downgrade	Buy → Neutral	—	$2.30	$2.34	+1.7%	+7.0%	-3.9%	-13.9%	-19.1%	-30.4%
Aug 28	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$1.47	$1.46	-0.7%	-8.2%	-7.5%	-6.8%	-8.8%	-10.2%
Aug 13	Stephens & Co.	Maintains	Overweight → Overweight	—	$1.43	$1.48	+3.5%	+4.2%	-5.6%	+18.2%	+9.1%	+11.9%
Aug 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$1.59	$1.58	-0.6%	-10.1%	-6.3%	-15.1%	+6.3%	-1.9%
Aug 8	Canaccord Genuity	Maintains	Buy → Buy	—	$1.53	$1.36	-11.1%	+9.2%	+3.9%	-6.5%	-2.6%	-11.8%
Aug 8	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$1.53	$1.36	-11.1%	+9.2%	+3.9%	-6.5%	-2.6%	-11.8%
May 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$2.23	$2.42	+8.5%	-3.6%	-1.8%	-9.4%	-13.9%	-17.9%
May 13	Piper Sandler	Maintains	Neutral → Neutral	—	$1.77	$1.81	+2.3%	+9.0%	+26.0%	+21.5%	+23.7%	+14.1%
May 10	Barclays	Maintains	Equal Weight → Equal Weight	—	$1.72	$1.72	+0.0%	+2.9%	+12.2%	+29.7%	+25.0%	+27.3%
Apr 22	JP Morgan	Downgrade	Overweight → Neutral	—	$1.55	$1.49	-3.9%	+0.6%	-5.2%	-12.3%	-11.0%	-5.2%
Apr 19	Goldman Sachs	Maintains	Neutral → Neutral	—	$1.46	$1.47	+0.7%	+6.2%	+6.8%	+0.7%	-6.8%	-5.5%
Apr 18	Goldman Sachs	Downgrade	Buy → Neutral	—	$1.40	$1.39	-0.7%	+4.3%	+10.7%	+11.4%	+5.0%	-2.9%
Apr 18	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$1.40	$1.39	-0.7%	+4.3%	+10.7%	+11.4%	+5.0%	-2.9%
Apr 18	Bernstein	Maintains	Outperform → Outperform	—	$1.40	$1.39	-0.7%	+4.3%	+10.7%	+11.4%	+5.0%	-2.9%
Apr 17	TD Cowen	Maintains	Buy → Buy	—	$1.40	$1.50	+7.1%	+0.0%	+4.3%	+10.7%	+11.4%	+5.0%
Apr 10	Goldman Sachs	Maintains	Buy → Buy	—	$3.61	$3.42	-5.3%	-7.8%	-6.4%	-12.2%	-21.3%	-61.2%
Apr 10	Barclays	Maintains	Equal Weight → Equal Weight	—	$3.61	$3.42	-5.3%	-7.8%	-6.4%	-12.2%	-21.3%	-61.2%
Mar 22	Canaccord Genuity	Maintains	Buy → Buy	—	$3.84	$3.79	-1.3%	-4.2%	-6.0%	-8.3%	-3.1%	-2.3%
Feb 16	UBS	Maintains	Buy → Buy	—	$6.67	$6.40	-4.0%	-13.9%	-20.7%	-23.8%	-23.1%	-23.4%
Nov 17	UBS	Upgrade	Neutral → Buy	—	$7.59	$7.82	+3.0%	+10.7%	+13.0%	+9.1%	+10.1%	+12.6%
Nov 6	Piper Sandler	Maintains	Neutral → Neutral	—	$7.22	$7.19	-0.4%	-5.8%	-4.7%	-7.3%	-9.7%	-9.7%
Oct 31	Cantor Fitzgerald	Upgrade	Neutral → Overweight	—	$7.11	$6.73	-5.3%	-13.1%	-16.0%	-8.3%	+1.5%	-4.4%
Oct 31	Canaccord Genuity	Maintains	Buy → Buy	—	$7.11	$6.73	-5.3%	-13.1%	-16.0%	-8.3%	+1.5%	-4.4%
Oct 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$7.26	$7.31	+0.7%	+0.6%	-7.4%	-1.5%	-2.1%	-2.1%
Oct 16	Piper Sandler	Maintains	Neutral → Neutral	—	$7.98	$7.78	-2.5%	+0.0%	+2.9%	-4.1%	-6.8%	-7.4%
Sep 29	Barclays	Maintains	Equal Weight → Equal Weight	—	$8.36	$8.46	+1.2%	-0.1%	-3.7%	-6.2%	-4.2%	-1.7%
Sep 26	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$8.46	$8.45	-0.1%	-2.7%	-1.2%	-1.2%	-1.3%	-4.8%
Aug 22	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$10.35	$10.37	+0.2%	-0.8%	+1.4%	-2.8%	-4.2%	-4.2%
Aug 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$11.52	$11.64	+1.0%	+5.7%	+3.6%	+4.1%	+1.4%	+3.4%
Aug 3	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$12.52	$12.75	+1.8%	-8.0%	-2.7%	-4.6%	-4.2%	-6.7%
Jun 5	Canaccord Genuity	Maintains	Buy → Buy	—	$13.49	$13.59	+0.7%	+0.7%	+1.0%	+3.6%	+3.2%	+2.1%
May 10	Barclays	Maintains	Equal Weight → Equal Weight	—	$12.03	$12.35	+2.7%	-1.0%	+1.0%	+1.3%	+3.4%	+1.7%